Enabling Continuous Innovation in Medical Device Manufacturing Through MES Modernization & Integration

Enabling Continuous Innovation in Medical Device Manufacturing Through MES Modernization & Integration

Client Overview

A U.S.-based global leader in continuous glucose monitoring (CGM) has been pioneering real-time health insights for over 25 years. Their advanced biosensing solutions empower millions of patients and clinicians worldwide to improve outcomes through continuous innovation.

Business Challenge

As the client scaled manufacturing and R&D operations, their existing Manufacturing Execution System (MES) faced mounting pressures to:

Athena’s Engagement

Since 2020, Athena has served as a strategic MES partner, delivering remote professional services to stabilize, upgrade, and integrate MES environments—migrating from earlier Siemens Opcenter releases to the latest high-complexity versions.

Key Milestones & Contributions

Business Impact

Athena’s partnership has enabled the client to operate on a robust, scalable, and integration-ready MES platform, resulting in:

Discover how a global leader in continuous glucose monitoring (CGM) partnered with Athena to modernize and integrate their Manufacturing Execution System (MES). By upgrading across multiple Siemens Opcenter versions, enabling real-time system integration, and supporting advanced R&D initiatives, Athena helped the client achieve scalable, reliable, and future-ready manufacturing operations.

Read the full case study to see how Athena drives MES performance, accelerates innovation, and empowers medical device leaders to deliver life-changing technologies at scale.